Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Blake Insomnia Therapeutics, Inc. (OTC: BKIT).

Full DD Report for BKIT

You must become a subscriber to view this report.

Recent News from (OTC: BKIT)

OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of November
NEW YORK , Dec. 4, 2017 /PRNewswire/ --   OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of   downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Designa...
Source: PR Newswire
Date: December, 04 2017 07:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BKIT.

About Blake Insomnia Therapeutics, Inc. (OTC: BKIT)

Logo for Blake Insomnia Therapeutics, Inc. (OTC: BKIT)

Blake Insomnia Therapeutics, Inc. is a New York based pharmaceutical company devoted to improving nighttime and daytime quality of life for people with insomnia. Our patent pending compound, Zleepax ZLX , has demonstrated efficacy without causing side effects which has been identified as the No. problem with current sleep medications.


Contact Information



Current Management

  • Birger Jan Olsen / CEO, CFO, President, Treasurer
    • Founder and CEO Birger Jan Olsen is a seasoned executive, inventor and marketer who has spent over years working primarily in pharmaceuticals and medical devices. In addition to Blake Insomnia Therapeutics, Birger has founded some business, including the pioneering neuromarketing company Mindmetic and ProjektGruppen, a successful pharmafocused marketing agency. As an inventor, Birger developed Blake s patentpending ZLX sleep medicine compound, along with a patented method for automatically interpreting brain activity, a complianceboosting dosing device for osteoporosis patients, acquired by Roche Pharmaceuticals, and the widely used Globase automated marketing tool, acquired by AdPepper. Birger s careerlong focus on startups has given him a wealth of experience with earlystage business processes, including fundraising and early organizational development.
  • Jillian Sidoti / Securities Counsel

Current Share Structure

  • Market Cap: $2,053,842 - 03/16/2018
  • Authorized: 100,000,000 - 03/01/2018
  • Issue and Outstanding: 31,597,572 - 03/01/2018
  • Float: 10,597,572 - 10/01/2016


Recent Filings from (OTC: BKIT)

Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 06 2017
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: September, 06 2017



Daily Technical Chart for (OTC: BKIT)

Daily Technical Chart for (OTC: BKIT)

Stay tuned for daily updates and more on (OTC: BKIT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BKIT)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BKIT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BKIT and does not buy, sell, or trade any shares of BKIT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: